Atlas Trials

Statin Adverse Reaction

21 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Statin Adverse Reaction

RecordFirmDate
Medicines Gaps Study (NCT05332158)The Leeds Teaching Hospitals NHS Trust2022-05-30
Effects of High Intensity Statin Therapy on Steroid Hormones and Vitamin D in Type 2 Diabetic Men (NCT05806723)Hopital La Rabta2021-03-01
Low Dose Rosuvastatin Plus Ezetimibe Versus High-dose Rosuvastatin in AMI (NCT04499859)Kiyuk Chang, MD,PhD2020-10-01
MUscle Side-Effects of Atorvastatin in Coronary Patients (MUSE) -Follow-up Study (NCT04453735)Vestre Viken Hospital Trust2020-08-19
The Association of Statins on Cardiorespiratory Fitness and Exercise Adaptation (NCT04986241)University of Sao Paulo General Hospital2019-09-20
Statin Intolerance in Patients With Myocardial Infarction (NCT04069598)Turkish Society of Cardiology2019-08-26
MUscle Side-Effects of Atorvastatin in Coronary Patients (NCT03874156)Vestre Viken Hospital Trust2019-03-05
7T Magnetic Resonance Spectroscopy and Skeletal Muscle Biopsy Findings in Statin Associated Adverse Muscle Events (NCT04507373)University of Texas Southwestern Medical Center2018-08-17
NIRS to Diagnose SAMS (NCT03653663)Hartford Hospital2018-01-01
Evaluation of Major Cardiovascular Events in Participants With, or at High Risk for, Cardiovascular Disease Who Are Statin Intolerant Treated With Bempedoic Acid (ETC-1002) or Placebo (NCT02993406)Esperion Therapeutics, Inc.2016-12-22
Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) as Add-on to Ezetimibe Therapy in Patients With Elevated LDL-C (CLEAR Tranquility) (NCT03001076)Esperion Therapeutics, Inc.2016-11-29
Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant (NCT02988115)Esperion Therapeutics, Inc.2016-11-16
Quality of Life in Patients With Statin-Associated Myopathy (NCT00850460)Rockefeller University2009-02-01

Track Statin Adverse Reaction automatically

Every clearance here is in the API, with alerts when new ones post.